Skip to content

Clinical trials

Completed Graft vs Host Disease trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Graft vs Host Disease Status: Completed Country / region: Italy Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20051
20061
20091
20101
20142
20175
20184
20192
20201
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
IRCCS Azienda Ospedaliero-Universitaria di Bologna3
Novartis Pharmaceuticals3
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia2
Incyte Corporation2
Mallinckrodt2
Pharmacyclics LLC.2
University of Pisa2
Ciceri Fabio1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
Fred Hutchinson Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Graft vs Host Disease24
Bronchiolitis Obliterans Syndrome4
Hematologic Neoplasms2
Hodgkin Disease1
Infections1
Leukemia1
Leukemia, Lymphocytic, Chronic, B-Cell1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive1
Leukemia, Myeloid, Acute1
Lymphoma, Follicular1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.